Sars-cov-2 vaccines
US-2024408193-A1 · Dec 12, 2024 · US
Highly efficient influenza matrix (M1) proteins
US8992939B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-8992939-B2 |
| Application number | US-201113280043-A |
| Country | US |
| Kind code | B2 |
| Filing date | Oct 24, 2011 |
| Priority date | Jul 11, 2003 |
| Publication date | Mar 31, 2015 |
| Grant date | Mar 31, 2015 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
This invention discloses a method of increasing production of virus-like particles comprising expressing an avian influenza matrix protein. The invention also comprises methods of making and using said VLPs.
First claim
Opening claim text (preview).
We claim: 1. A virus-like particle (VLP) comprising an influenza M1 protein and at least one of an influenza hemacelutinin (HA) protein and an influenza neuraminidase (NA) protein, wherein said M1 protein comprises the amino acid residues YKKL at the positions corresponding to positions 100-103 of SEQ ID NO: 49, wherein the VLP lacks a viral genome and is non-infectious. 2. The VLP of claim 1 , wherein said influenza M1 protein is derived from an avian influenz…
Assignees
Inventors
Classifications
Human Necessities · mapped topic
Human Necessities · mapped topic
Chemistry & Metallurgy · mapped topic
Chemistry & Metallurgy · mapped topic
Chemistry & Metallurgy · mapped topic
Patent family
Related publications grouped by family.
External sources
Next steps
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US8992939B2 cover?
- This invention discloses a method of increasing production of virus-like particles comprising expressing an avian influenza matrix protein. The invention also comprises methods of making and using said VLPs.
- Who is the assignee on this patent?
- Smith Gale, Wu Yingyun, Massare Michael, and 5 more
- What technology area does this patent fall under?
- Primary CPC classification A61K39/12. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue Mar 31 2015 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).